|
Thursday, Aug 11, 2011
MD Biosciences
MD Biosciences , a Preclinical Contract Research Organization (CRO), offers in vivo models for the study of Parkinson's Disease (PD) . The 6-OHDA and acute MPTP models for PD have been well characterized with the underlying mechanisms of toxicity... Read More
|
|
Wednesday, Jul 13, 2011
MD Biosciences
MD Biosciences, a preclinical CRO focused in pain and inflammations, has released a new eBook discussing the interactions between the nervous and immune systems and the drug targets that may lie in the overlap. This newly published eBook... Read More
|
|
Thursday, Feb 3, 2011
MD Biosciences
MD Biosciences, a global biotechnology company focused in inflammations research, has optimized ArthritoMabTM Antibody Cocktail for the induction of arthritis in C57Bl/6. Using the optimized ArthritoMab Antibody Cocktail ,... Read More
|
|
Wednesday, Jun 16, 2010
MD Biosciences
Wednesday, June 16, 2010, St. Paul, MN - MD Biosciences, a Preclinical Contract Research Organization (CRO), offers in vivo models for the study of myocardial infarct (MI). The occlusion-induced myocardial infarct model is a well-known... Read More
|
|
Tuesday, Oct 6, 2009
MD Biosciences
MD Biosciences (MDB) launches MD Bioproducts, a division of MD Biosciences, in a continued effort to meet client needs for high quality research products. The new division allows MD Biosciences to strengthen and expand it's... Read More
|